BioCentury
ARTICLE | Financial News

ADC Therapeutics completes venture financing

October 24, 2016 7:00 AM UTC

ADC Therapeutics S.A., Epilanges, SwitzerlandBusiness: CancerDate completed: 2016-10-18Type: Venture financingRaised: $105 millionInvestors: Auven Therapeutics Management; Wild Family Office; AstraZen...